Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Aroa Biosurgery Limited market cap is $163.28M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aroa Biosurgery Limited 52 week high is $0.522 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aroa Biosurgery Limited 52 week low is $0.3845 as of November 18, 2026.
Aroa Biosurgery Limited stock price today is $0.4726.
Aroa Biosurgery Limited stock price yesterday was $0.52.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Aroa Biosurgery Limited's P/E ratio is 60.59.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Aroa Biosurgery Limited P/B ratio is 2.8777.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Aroa Biosurgery Limited 50-day moving average is $0.4745.